Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient

Nephrology Dialysis Transplantation

Volumn 19, Issue 3, 2004, Pages 723-726

  Kunin, Margarita ^a,b   Kopolovic, Juri ^a,b   Avigdor, Abraham ^a,b   Holtzman, Eliezer J ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Biophosphonates; Collapsing glomerulopathy; Multiple myeloma; Pamidronate

Indexed keywords

ALPHA INTERFERON; BISPHOSPHONIC ACID DERIVATIVE; DEXAMETHASONE; DOXORUBICIN; PAMIDRONIC ACID; PARAPROTEIN; PREDNISONE; THALIDOMIDE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE LESION; CANCER REGRESSION; CASE REPORT; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; EPITHELIUM HYPERPLASIA; FEMALE; GLOMERULOPATHY; GLOMERULUS CAPILLARY; GLOMERULUS EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; KIDNEY HYPERTROPHY; KIDNEY INJURY; LONG TERM CARE; MULTIPLE MYELOMA; NEPHROTOXICITY; PATIENT MONITORING; PATIENT REFERRAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

ANTINEOPLASTIC AGENTS; BASEMENT MEMBRANE; DIPHOSPHONATES; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 1342306180     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg567     Document Type: Article

References (19)

1. Rogers MJ, Gordon S, Benford HL et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 2000; 88: 2961-2978
2. Hughes DE, Wright KR, Uy HL et al. Bisphosphonates promotes apoptosis in marine osteoclasts in vitro and in vivo. J Bone Miner Res 1995; 10: 1478-1487
3. Banerjee D, Asif A, Striker L, Preston RA, Bourgoignie JJ, Roth D. Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonates nephrotoxicity. Am J Kidney Dis 2003; 41: 1-6
4. Markowitz G, Appel G, Fine P et al. Collapsing focal segmental glomerulosclerosis following treatment with highdose pamidronate. J Am Soc Nephrol 2001; 12: 1164-1172
5. Markowitz G, Fine P, D'Agati V. Nephrotic syndrome after treatment with pamidronate. Am J Kidney Dis 2002; 39: 1118-1122
6. Lockridge L, Papac R, Perazella M. Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis. Am J Kidney Dis 2002; 40: 1-36
7. Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 1994; 45: 1416-1424
8. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int 1996; 50: 1734-1746
9. D'Agati VD, Suh J, Carbone L, Appel GB. The pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 1989; 35: 1358-1370
10. Moudgil A, Nast CC, Bagga A et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001; 59: 2126-2133
11. Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 2000; 35: 1166-1174
12. Li RM, Branton M, Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002; 13: 2320-2330
13. Schwartz MM. The role of podocytes injury in the pathogenesis of focal segmental glomerulosclerosis. Ren Fail 2000; 22: 663-684
14. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocytes phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10: 51-61
15. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocytes proliferation and maturation. Kidney Int 2000; 58: 674-683
16. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z. Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103-111
17. Ortiz A. Apoptotic regulatory proteins in renal injury. Kidney Int 2000; 58: 467-485
18. Oda T, Hotta O, Taguma Y et al. Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis. Kidney Int 1998; 53: 1190-1200
19. Bariety J, Nochy D, Mandet C et al. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998; 53: 918-925